148 related articles for article (PubMed ID: 22213451)
21. Grb10 and Grb14: enigmatic regulators of insulin action--and more?
Holt LJ; Siddle K
Biochem J; 2005 Jun; 388(Pt 2):393-406. PubMed ID: 15901248
[TBL] [Abstract][Full Text] [Related]
22. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
[TBL] [Abstract][Full Text] [Related]
23. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
[TBL] [Abstract][Full Text] [Related]
24. Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists.
Ambaye ND; Gunzburg MJ; Lim RC; Price JT; Wilce MC; Wilce JA
Bioorg Med Chem; 2011 Jan; 19(1):693-701. PubMed ID: 21134757
[TBL] [Abstract][Full Text] [Related]
25. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor.
Thömmes K; Lennartsson J; Carlberg M; Rönnstrand L
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):211-6. PubMed ID: 10377264
[TBL] [Abstract][Full Text] [Related]
26. Grb7 binds to Hax-1 and undergoes an intramolecular domain association that offers a model for Grb7 regulation.
Siamakpour-Reihani S; Peterson TA; Bradford AM; Argiros HJ; Haas LL; Lor SN; Haulsee ZM; Spuches AM; Johnson DL; Rohrschneider LR; Shuster CB; Lyons BA
J Mol Recognit; 2011; 24(2):314-21. PubMed ID: 20665473
[TBL] [Abstract][Full Text] [Related]
27. Specificity and affinity motifs for Grb2 SH2-ligand interactions.
Kessels HW; Ward AC; Schumacher TN
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8524-9. PubMed ID: 12084912
[TBL] [Abstract][Full Text] [Related]
28. Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain.
Spuches AM; Argiros HJ; Lee KH; Haas LL; Pero SC; Krag DN; Roller PP; Wilcox DE; Lyons BA
J Mol Recognit; 2007; 20(4):245-52. PubMed ID: 17705331
[TBL] [Abstract][Full Text] [Related]
29. Association of Grb7 with phosphoinositides and its role in the regulation of cell migration.
Shen TL; Han DC; Guan JL
J Biol Chem; 2002 Aug; 277(32):29069-77. PubMed ID: 12021278
[TBL] [Abstract][Full Text] [Related]
30. Adaptor signalling proteins Grb2 and Grb7 are recruited by human G6f, a novel member of the immunoglobulin superfamily encoded in the MHC.
De Vet EC; Aguado B; Campbell RD
Biochem J; 2003 Oct; 375(Pt 1):207-13. PubMed ID: 12852788
[TBL] [Abstract][Full Text] [Related]
31. Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.
Lung FD; Tsai JY
Biopolymers; 2003; 71(2):132-40. PubMed ID: 12767115
[TBL] [Abstract][Full Text] [Related]
32. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.
He W; Rose DW; Olefsky JM; Gustafson TA
J Biol Chem; 1998 Mar; 273(12):6860-7. PubMed ID: 9506989
[TBL] [Abstract][Full Text] [Related]
33. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
34. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
[TBL] [Abstract][Full Text] [Related]
35. Sequence analysis identifies a ras-associating (RA)-like domain in the N-termini of band 4.1/JEF domains and in the Grb7/10/14 adapter family.
Wojcik J; Girault JA; Labesse G; Chomilier J; Mornon JP; Callebaut I
Biochem Biophys Res Commun; 1999 May; 259(1):113-20. PubMed ID: 10334925
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional studies of the Ras-associating and pleckstrin-homology domains of Grb10 and Grb14.
Depetris RS; Wu J; Hubbard SR
Nat Struct Mol Biol; 2009 Aug; 16(8):833-9. PubMed ID: 19648926
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
[TBL] [Abstract][Full Text] [Related]
39. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
Song YL; Tan J; Luo XM; Long YQ
Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
[TBL] [Abstract][Full Text] [Related]
40. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain.
Thornton KH; Mueller WT; McConnell P; Zhu G; Saltiel AR; Thanabal V
Biochemistry; 1996 Sep; 35(36):11852-64. PubMed ID: 8794768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
